A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
NCT02950064
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
95
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatic Neoplasms
Ovarian Neoplasms
Breast Neoplasms
Prostatic Neoplasms
Interventions
DRUG:
BTP-114
Sponsor
Placon Therapeutics